US Stock MarketDetailed Quotes

IDYA IDEAYA Biosciences

Watchlist

40.640
-0.770-1.86%

Close May 9 16:00 ET

3.08BMarket Cap-20320P/E (TTM)

IDEAYA Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-57.36%-43.81M

-32.18%-115.22M

-1.62%-23.75M

-24.86%-30.17M

-67.37%-33.46M

-41.71%-27.84M

-56.29%-87.18M

-40.30%-23.37M

-93.82%-24.17M

-54.62%-19.99M

Net income from continuing operations

-67.39%-39.57M

-92.59%-112.96M

-40.30%-33.96M

-1,799.07%-27.44M

-26.61%-27.93M

-68.70%-23.64M

-17.87%-58.66M

-32.88%-24.2M

113.94%1.62M

-101.48%-22.06M

Depreciation and amortization

12.71%1.08M

14.03%4.01M

11.06%1.02M

10.92%1.03M

16.05%998K

18.81%960K

15.93%3.52M

17.60%922K

18.59%925K

-20.81%860K

Change In working capital

26.75%-5.32M

69.26%-13.21M

526.04%8.26M

81.45%-5.5M

-333.50%-8.71M

22.69%-7.26M

-124.73%-42.97M

-10.05%-1.94M

-584.34%-29.63M

63.94%-2.01M

-Change in receivables

101.17%3K

-78.36%193K

106.45%6.69M

-106.99%-6.54M

-24.69%308K

-163.30%-257K

15.25%892K

3,909.41%3.24M

-1,129.64%-3.16M

-74.39%409K

-Change in prepaid assets

-328.19%-3.13M

3.49%-2.05M

55.50%-724K

369.16%1.19M

-760.53%-3.88M

243.25%1.37M

-1,021.16%-2.12M

-889.81%-1.63M

-133.31%-441K

76.49%-451K

-Change in payables and accrued expense

-300.46%-1.73M

-33.65%4.27M

486.94%4.23M

144.65%1.72M

-130.91%-1.24M

-142.97%-431K

19.67%6.44M

53.52%720K

-70.66%701K

39.55%4.01M

-Change in other current liabilities

-3.10%-465K

-10.18%-1.87M

-10.18%-487K

-10.21%-475K

-10.07%-459K

-10.27%-451K

-10.18%-1.7M

-10.22%-442K

-9.95%-431K

-10.61%-417K

-Change in other working capital

----

70.41%-13.75M

62.41%-1.44M

94.76%-1.38M

38.21%-3.44M

30.55%-7.5M

-97.44%-46.48M

-96.21%-3.83M

-230.44%-26.29M

25.15%-5.56M

Cash from discontinued investing activities

Operating cash flow

-57.36%-43.81M

-32.18%-115.22M

-1.62%-23.75M

-24.86%-30.17M

-67.37%-33.46M

-41.71%-27.84M

-56.29%-87.18M

-40.30%-23.37M

-93.82%-24.17M

-54.62%-19.99M

Investing cash flow

Cash flow from continuing investing activities

-1,604.91%-353.97M

-374.36%-158.46M

-989.36%-111.94M

374.83%51.35M

-1,011.54%-121.38M

232.43%23.52M

52.05%-33.4M

-2,388.14%-10.28M

66.82%-18.68M

126.97%13.32M

Net PPE purchase and sale

-2,981.40%-1.33M

31.22%-2.37M

---838K

45.23%-603K

54.46%-884K

89.28%-43K

-30.22%-3.44M

--0

-140.39%-1.1M

-235.81%-1.94M

Net investment purchase and sale

-1,596.55%-352.65M

-420.97%-156.09M

-981.21%-111.11M

395.47%51.95M

-889.78%-120.5M

235.74%23.56M

55.30%-29.96M

-5,452.08%-10.28M

68.52%-17.58M

131.26%15.26M

Cash from discontinued investing activities

Investing cash flow

-1,604.91%-353.97M

-374.36%-158.46M

-989.36%-111.94M

374.83%51.35M

-1,011.54%-121.38M

232.43%23.52M

52.05%-33.4M

-2,388.14%-10.28M

66.82%-18.68M

126.97%13.32M

Financing cash flow

Cash flow from continuing financing activities

11,831.34%349.11M

273.30%362.72M

43,385.80%140.89M

-70.91%27.83M

38,813.03%191.06M

348.09%2.93M

-33.20%97.17M

-52.91%324K

10.28%95.7M

-96.93%491K

Net common stock issuance

13,323.83%343.65M

226.20%309.76M

24,937.82%127.42M

-72.81%25.98M

233,139.39%153.81M

28,544.44%2.56M

-33.71%94.96M

-2,130.43%-513K

11.15%95.55M

-100.43%-66K

Net preferred stock issuance

----

--42.18M

----

--0

----

Proceeds from stock option exercised by employees

1,392.08%5.46M

388.97%10.77M

-3,529.63%-28.71M

1,161.90%1.86M

6,588.87%37.26M

-44.71%366K

0.09%2.2M

17.72%837K

-81.81%147K

-2.28%557K

Cash from discontinued financing activities

Financing cash flow

11,831.34%349.11M

273.30%362.72M

43,385.80%140.89M

-70.91%27.83M

38,813.03%191.06M

348.09%2.93M

-33.20%97.17M

-52.91%324K

10.28%95.7M

-96.93%491K

Net cash flow

Beginning cash position

129.53%157.78M

-25.41%68.74M

49.49%152.57M

110.45%103.57M

21.56%67.34M

-25.41%68.74M

27.74%92.15M

-5.96%102.06M

-45.64%49.21M

-59.52%55.4M

Current changes in cash

-3,389.10%-48.67M

480.27%89.04M

115.61%5.2M

-7.27%49.01M

685.64%36.22M

96.20%-1.4M

-217.02%-23.41M

-103.41%-33.32M

193.58%52.85M

86.65%-6.19M

End cash Position

62.01%109.1M

129.53%157.78M

49.49%152.57M

110.45%103.57M

21.56%67.34M

-25.41%68.74M

-5.96%102.06M

-45.64%49.21M

Free cash flow

-61.87%-45.14M

-29.77%-117.59M

-5.20%-24.59M

-21.81%-30.78M

-56.59%-34.34M

-39.09%-27.89M

-55.11%-90.62M

-35.38%-23.37M

-95.47%-25.27M

-62.37%-21.93M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-57.36%-43.81M	-32.18%-115.22M	-1.62%-23.75M	-24.86%-30.17M	-67.37%-33.46M	-41.71%-27.84M	-56.29%-87.18M	-40.30%-23.37M	-93.82%-24.17M	-54.62%-19.99M
Net income from continuing operations	-67.39%-39.57M	-92.59%-112.96M	-40.30%-33.96M	-1,799.07%-27.44M	-26.61%-27.93M	-68.70%-23.64M	-17.87%-58.66M	-32.88%-24.2M	113.94%1.62M	-101.48%-22.06M
Depreciation and amortization	12.71%1.08M	14.03%4.01M	11.06%1.02M	10.92%1.03M	16.05%998K	18.81%960K	15.93%3.52M	17.60%922K	18.59%925K	-20.81%860K
Change In working capital	26.75%-5.32M	69.26%-13.21M	526.04%8.26M	81.45%-5.5M	-333.50%-8.71M	22.69%-7.26M	-124.73%-42.97M	-10.05%-1.94M	-584.34%-29.63M	63.94%-2.01M
-Change in receivables	101.17%3K	-78.36%193K	106.45%6.69M	-106.99%-6.54M	-24.69%308K	-163.30%-257K	15.25%892K	3,909.41%3.24M	-1,129.64%-3.16M	-74.39%409K
-Change in prepaid assets	-328.19%-3.13M	3.49%-2.05M	55.50%-724K	369.16%1.19M	-760.53%-3.88M	243.25%1.37M	-1,021.16%-2.12M	-889.81%-1.63M	-133.31%-441K	76.49%-451K
-Change in payables and accrued expense	-300.46%-1.73M	-33.65%4.27M	486.94%4.23M	144.65%1.72M	-130.91%-1.24M	-142.97%-431K	19.67%6.44M	53.52%720K	-70.66%701K	39.55%4.01M
-Change in other current liabilities	-3.10%-465K	-10.18%-1.87M	-10.18%-487K	-10.21%-475K	-10.07%-459K	-10.27%-451K	-10.18%-1.7M	-10.22%-442K	-9.95%-431K	-10.61%-417K
-Change in other working capital	----	70.41%-13.75M	62.41%-1.44M	94.76%-1.38M	38.21%-3.44M	30.55%-7.5M	-97.44%-46.48M	-96.21%-3.83M	-230.44%-26.29M	25.15%-5.56M
Cash from discontinued investing activities
Operating cash flow	-57.36%-43.81M	-32.18%-115.22M	-1.62%-23.75M	-24.86%-30.17M	-67.37%-33.46M	-41.71%-27.84M	-56.29%-87.18M	-40.30%-23.37M	-93.82%-24.17M	-54.62%-19.99M
Investing cash flow
Cash flow from continuing investing activities	-1,604.91%-353.97M	-374.36%-158.46M	-989.36%-111.94M	374.83%51.35M	-1,011.54%-121.38M	232.43%23.52M	52.05%-33.4M	-2,388.14%-10.28M	66.82%-18.68M	126.97%13.32M
Net PPE purchase and sale	-2,981.40%-1.33M	31.22%-2.37M	---838K	45.23%-603K	54.46%-884K	89.28%-43K	-30.22%-3.44M	--0	-140.39%-1.1M	-235.81%-1.94M
Net investment purchase and sale	-1,596.55%-352.65M	-420.97%-156.09M	-981.21%-111.11M	395.47%51.95M	-889.78%-120.5M	235.74%23.56M	55.30%-29.96M	-5,452.08%-10.28M	68.52%-17.58M	131.26%15.26M
Cash from discontinued investing activities
Investing cash flow	-1,604.91%-353.97M	-374.36%-158.46M	-989.36%-111.94M	374.83%51.35M	-1,011.54%-121.38M	232.43%23.52M	52.05%-33.4M	-2,388.14%-10.28M	66.82%-18.68M	126.97%13.32M
Financing cash flow
Cash flow from continuing financing activities	11,831.34%349.11M	273.30%362.72M	43,385.80%140.89M	-70.91%27.83M	38,813.03%191.06M	348.09%2.93M	-33.20%97.17M	-52.91%324K	10.28%95.7M	-96.93%491K
Net common stock issuance	13,323.83%343.65M	226.20%309.76M	24,937.82%127.42M	-72.81%25.98M	233,139.39%153.81M	28,544.44%2.56M	-33.71%94.96M	-2,130.43%-513K	11.15%95.55M	-100.43%-66K
Net preferred stock issuance	----	--42.18M	----	----	----	----	--0	----	----	----
Proceeds from stock option exercised by employees	1,392.08%5.46M	388.97%10.77M	-3,529.63%-28.71M	1,161.90%1.86M	6,588.87%37.26M	-44.71%366K	0.09%2.2M	17.72%837K	-81.81%147K	-2.28%557K
Cash from discontinued financing activities
Financing cash flow	11,831.34%349.11M	273.30%362.72M	43,385.80%140.89M	-70.91%27.83M	38,813.03%191.06M	348.09%2.93M	-33.20%97.17M	-52.91%324K	10.28%95.7M	-96.93%491K
Net cash flow
Beginning cash position	129.53%157.78M	-25.41%68.74M	49.49%152.57M	110.45%103.57M	21.56%67.34M	-25.41%68.74M	27.74%92.15M	-5.96%102.06M	-45.64%49.21M	-59.52%55.4M
Current changes in cash	-3,389.10%-48.67M	480.27%89.04M	115.61%5.2M	-7.27%49.01M	685.64%36.22M	96.20%-1.4M	-217.02%-23.41M	-103.41%-33.32M	193.58%52.85M	86.65%-6.19M
End cash Position	62.01%109.1M	129.53%157.78M	129.53%157.78M	49.49%152.57M	110.45%103.57M	21.56%67.34M	-25.41%68.74M	-25.41%68.74M	-5.96%102.06M	-45.64%49.21M
Free cash flow	-61.87%-45.14M	-29.77%-117.59M	-5.20%-24.59M	-21.81%-30.78M	-56.59%-34.34M	-39.09%-27.89M	-55.11%-90.62M	-35.38%-23.37M	-95.47%-25.27M	-62.37%-21.93M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall